Europe Medical Cannabis Market Growth, Demand and Challenges of the Key Industry Players 2024-2032
                     Europe Medical Cannabis 
Market Research and 
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
A c c o r d i n g  t o  t h e  l a t e s t  r e p o r t  b y  I M A R C  G r o u p ,  t i t l e d  " E u r o p e  M e d i c a l  C a n n a b i s  M a r k e t :  
I n d u s t r y  T r e n d s ,  S h a r e ,  S i z e ,  G r o w t h ,  O p p o r t u n i t y  a n d  F o r e c a s t  2 0 2 4 - 2 0 3 2 , "  t h e  E u r o p e  
m e d i c a l  c a n n a b i s  m a r k e t  s i z e  r e a c h e d  U S $  2 , 1 6 7 . 8  M i l l i o n  i n  2 0 2 3 .
M e d i c a l  c a n n a b i s ,  a l s o  k n o w n  a s  m e d i c a l  m a r i j u a n a ,  r e f e r s  t o  t h e  u s e  o f  t h e  c a n n a b i s  p l a n t  o r  
i t s  e x t r a c t s  t o  t r e a t  v a r i o u s  m e d i c a l  c o n d i t i o n s  a n d  a l l e v i a t e  s y m p t o m s .  T h e  p l a n t  c o n t a i n s  
Report o v e r  1 0 0  d i f f e r e n t  c a n n a b i n o i d s ,  w i t h  t e t r a h y d r o c a n n a b i n o l  ( T H C )  a n d  c a n n a b i d i o l  ( C B D )  b e i n g  t h e  m o s t  w e l l - k n o w n  a n d  s t u d i e d .  T h e s e  c a n n a b i n o i d s  i n t e r a c t  w i t h  t h e  b o d y ' s  
e n d o c a n n a b i n o i d  s y s t e m ,  w h i c h  p l a y s  a  c r u c i a l  r o l e  i n  r e g u l a t i n g  v a r i o u s  p h y s i o l o g i c a l  
Highlight and f u n c t i o n s ,  i n c l u d i n g  p a i n  s e n s a t i o n ,  m o o d ,  a p p e t i t e ,  a n d  m e m o r y .  M e d i c a l  c a n n a b i s  c a n  b e  a d m i n i s t e r e d  t h r o u g h  v a r i o u s  m e t h o d s ,  i n c l u d i n g  s m o k i n g ,  v a p o r i z a t i o n ,  i n g e s t i o n  o f  c a p s u l e s  
o r  e d i b l e s ,  a n d  t o p i c a l  a p p l i c a t i o n .  
Description I t  h a s  b e e n  u s e d  f o r  c e n t u r i e s  f o r  i t s  t h e r a p e u t i c  p r o p e r t i e s  a n d  i s  n o w  g a i n i n g  i n c r e a s i n g  r e c o g n i t i o n  a n d  a c c e p t a n c e  w i t h i n  t h e  m e d i c a l  c o m m u n i t y  f o r  i t s  p o t e n t i a l  i n  m a n a g i n g  c h r o n i c  
p a i n ,  n a u s e a  a n d  v o m i t i n g ,  m u s c l e  s p a s m s ,  s e i z u r e s ,  i n f l a m m a t i o n ,  a n d  o t h e r  c o n d i t i o n s .  
M e d i c a l  c a n n a b i s  i s  t y p i c a l l y  p r e s c r i b e d  b y  h e a l t h c a r e  p r o f e s s i o n a l s  i n  j u r i s d i c t i o n s  w h e r e  i t  
i s  l e g a l ,  a n d  p a t i e n t s  m a y  o b t a i n  i t  f r o m  l i c e n s e d  d i s p e n s a r i e s  o r  p h a r m a c i e s .
R e q u e s t  f o r  a  P D F  s a m p l e  o f  t h i s  r e p o r t :  
h t t p s : / / w w w . i m a r c g r o u p . c o m / e u r o p e - m e d i c a l - c a n n a b i s - m a r k e t / r e q u e s t s a m p l e
Report Description
E u r o p e  M e d ic a l  C a n n a b i s  M a r k e t  T r e n d s :
T h e  E u r o p e  m e d i c a l  c a n n a b i s  m a r k e t  i s  e x p e r i e n c i n g  s i g n i f i c a n t  g r o w t h  d r i v e n  b y  t h e  g r o w i n g  b o d y  o f  s c i e n t i f i c  r e s e a r c h  s u p p o r t i n g  t h e  
t h e r a p e u t i c  b e n e f i t s  o f  m e d i c a l  c a n n a b i s  a c r o s s  a  w i d e  r a n g e  o f  m e d i c a l  c o n d i t i o n s .  T h i s  i n c r e a s i n g  e v i d e n c e  b a s e  i s  l e a d i n g  t o  g r e a t e r  
a c c e p t a n c e  a n d  a d o p t i o n  o f  m e d i c a l  c a n n a b i s  a m o n g  h e a l t h c a r e  p r o f e s s i o n a l s  a n d  p a t i e n t s  a l i k e .  B e s i d e s ,  t h e r e  i s  a  r i s i n g  d e m a n d  f o r  
a l t e r n a t i v e  t r e a t m e n t  o p t i o n s ,  p a r t i c u l a r l y  f o r  c h r o n i c  a n d  d e b i l i t a t i n g  c o n d i t i o n s  w h e r e  c o n v e n t i o n a l  t h e r a p i e s  m a y  b e  i n a d e q u a t e  o r  
a s s o c i a t e d  w i t h  u n d e s i r a b l e  s i d e  e f f e c t s .  M e d i c a l  c a n n a b i s  o f f e r s  a  p r o m i s i n g  a l t e r n a t i v e  o r  a d j u n c t i v e  t h e r a p y  f o r  p a t i e n t s  s e e k i n g  r e l i e f  
f r o m  s y m p t o m s  s u c h  a s  c h r o n i c  p a i n ,  s p a s t i c i t y ,  a n d  c h e m o t h e r a p y - i n d u c e d  n a u s e a  a n d  v o m i t i n g .  
M o r e o v e r ,  t h e r e  i s  a  s h i f t i n g  r e g u l a t o r y  l a n d s c a p e  a c r o s s  E u r o p e ,  w i t h  a n  i n c r e a s i n g  n u m b e r  o f  c o u n t r i e s  l e g a l i z i n g  m e d i c a l  c a n n a b i s  o r  
e x p a n d i n g  a c c e s s  t o  i t  f o r  m e d i c a l  p u r p o s e s .  T h i s  t r e n d  i s  d r i v e n  b y  e v o l v i n g  a t t i t u d e s  t o w a r d s  c a n n a b i s ,  a s  w e l l  a s  r e c o g n i t i o n  o f  i t s  
p o t e n t i a l  e c o n o m i c  b e n e f i t s ,  i n c l u d i n g  j o b  c r e a t i o n ,  t a x  r e v e n u e ,  a n d  r e d u c e d  b u r d e n  o n  h e a l t h c a r e  s y s t e m s .  A d d i t i o n a l l y ,  t h e r e  i s  a  
g r o w i n g  t r e n d  t o w a r d  m e d i c a l i z a t i o n  a n d  s t a n d a r d i z a t i o n  o f  c a n n a b i s  p r o d u c t s ,  w i t h  c o m p a n i e s  i n v e s t i n g  i n  r e s e a r c h ,  d e v e l o p m e n t ,  a n d  
q u a l i t y  c o n t r o l  t o  e n s u r e  c o n s i s t e n c y ,  s a f e t y ,  a n d  e f f i c a c y .  T h i s  i n c l u d e s  t h e  d e v e l o p m e n t  o f  p h a r m a c e u t i c a l - g r a d e  c a n n a b i s - b a s e d  
m e d i c i n e s ,  a s  w e l l  a s  i n n o v a t i v e  d e l i v e r y  m e t h o d s  a n d  f o r m u l a t i o n s  t a i l o r e d  t o  s p e c i f i c  p a t i e n t  n e e d s .  O v e r a l l ,  t h e s e  d r i v e r s  a n d  t r e n d s  
a r e  e x p e c t e d  t o  f u e l  c o n t i n u e d  g r o w t h  a n d  e x p a n s i o n  o f  t h e  E u r o p e  m e d i c a l  c a n n a b i s  m a r k e t  i n  t h e  c o m i n g  y e a r s ,  p r e s e n t i n g  o p p o r t u n i t i e s  
f o r  c o m p a n i e s  t o  c a p i t a l i z e  o n  t h i s  b u r g e o n i n g  i n d u s t r y .
V ie w  R e p o r t  T O C ,  F i g u r e s  a n d  T a b l e s :  h t t p s : / / w w w . i m a r c g r o u p . c o m / e u r o p e - m e d i c a l - c a n n a b i s - m a r k e t
Breakup by Species:
• Indica
• Sat iva
• Hybrid
 
Breakup by Derivative:
Report • Cannabidiol  (CBD)
• Tetrahydrocannabinol  (THC)
Segmentation • Others
Breakup by Application:
• Cancer
• Arthr it is
• Migraine
• Epi lepsy
• Others
Breakup by End Use:
• Pharmaceutical  Industry
• Research and Development Centers
Report • Others
 
Segmentation
Breakup by Route of Administration:
• Oral  Solut ions and Capsules
• Smoking
• Vapor izers
• Topicals
• Others
Breakup by Country:
• Germany
• France
• United Kingdom
• I ta ly
• Spain
Report 
• Others
Segmentation
What was the size of the Europe medical cannabis 
market in 2023?
What is the expected growth rate of the Europe 
medical cannabis market during 2024-2032?
Key 
Questions What are the key factors driving the Europe medical cannabis market?
Answered in 
What has been the impact of COVID-19 on the 
the Report Europe medical cannabis market?
What is the breakup of the Europe medical 
cannabis market based on the species?
What is the breakup of the Europe medical 
cannabis market based on the derivative?
What is the breakup of the Europe medical 
cannabis market based on the application?
What is the breakup of the Europe medical 
cannabis market based on end use?
Key 
What is the breakup of the Europe medical 
Questions cannabis market based on the route of administration?
Answered in 
What are the key regions in the Europe medical 
the Report cannabis market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
        2 . 4 . 1     B o t t o m - U p  A p p r o a c h
Table of         2 . 4 . 2     T o p - D o w n  A p p r o a c h    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
    4 . 1     O v e r v i e w
Contents     4 . 2     K e y  I n d u s t r y  T r e n d s5     E u r o p e  M e d i c a l  C a n n a b i s  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  S p e c i e s
    6 . 1     I n d i c a
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     S a t i v a
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
    6 . 3     H y b r i d
        6 . 3 . 1  M a r k e t  T r e n d s
        6 . 3 . 2  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  D e r i v a t i v e
       
    7 . 1     C a n n a b i d i o l  ( C B D )
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
    7 . 2     T e t r a h y d r o c a n n a b i n o l  ( T H C )
        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
    7 . 3     O t h e r s
        7 . 3 . 1  M a r k e t  T r e n d s
        7 . 3 . 2  M a r k e t  F o r e c a s t
8    M a r k e t  B r e a k u p  b y  A p p l i c a t i o n
    8 . 1     C a n c e r
Table of         8 . 1 . 1  M a r k e t  T r e n d s        8 . 1 . 2  M a r k e t  F o r e c a s t
    8 . 2     A r t h r i t i s
        8 . 2 . 1  M a r k e t  T r e n d s
Contents         8 . 2 . 2  M a r k e t  F o r e c a s t
    8 . 3     M i g r a i n e
        8 . 3 . 1  M a r k e t  T r e n d s
        8 . 3 . 2  M a r k e t  F o r e c a s t
    8 . 4     E p i l e p s y
        8 . 4 . 1  M a r k e t  T r e n d s
        8 . 4 . 2  M a r k e t  F o r e c a s t
    8 . 5     O t h e r s
        8 . 5 . 1  M a r k e t  T r e n d s
        8 . 5 . 2  M a r k e t  F o r e c a s t
9    M a r k e t  B r e a k u p  b y  E n d  U s e
    9 . 1     P h a r m a c e u t i c a l  I n d u s t r y
        9 . 1 . 1  M a r k e t  T r e n d s
        9 . 1 . 2  M a r k e t  F o r e c a s t     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m /e uro p e -m ed i c a l - c a nna b i s -m a rke
t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: